Assessment of a modified MINDS ‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2023
DOI: 10.1002/phar.2855 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023. Verfasst von Kevin M Krcmarik und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section of Hospitalist Medicine, Jennifer Moreno Veterans Affairs Medical Center, San Diego, California, USA. Hauptthemen laut MEDLINE: Substance Withdrawal Syndrome, Alcoholism, Alcohol Withdrawal Delirium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objective
To determine if a novel symptom‐based alcohol withdrawal syndrome (AWS) protocol in a US Veterans cohort leads to significant clinical improvements in patient outcomes and safety.
Background
Prior studies of AWS management, oftentimes using the revised version of the Clinical Institute Withdrawal Assessment for Alcohol (CIWA‐Ar) index, have demonstrated the effectiveness of symptom‐triggered therapy for AWS. The Minnesota Detoxification Scale (MINDS) is an alternative to the CIWA‐Ar index but remains unevaluated outside of the intensive care unit (ICU) setting. This study assesses outcomes in AWS management prior to and after the implementation of a novel MINDS‐based AWS protocol (SDAWP) utilizing a revised MINDS index (MINDS‐rev) in an inpatient medical ward setting.
Methods
Retrospective cohort study including encounters prior to ( n = 342) and after ( n = 338) the implementation of the protocol. Pre‐ and post‐protocol encounters were selected by combinations of diagnostic codes and charting elements. Outcome measures of AWS management were obtained in both groups. The primary endpoint was median total benzodiazepine exposure. Secondary outcomes included median length of hospitalization, median duration of benzodiazepine administration, and the incidence of complications.
Results
The median total benzodiazepine exposure in the post‐SDAWP group was significantly lower than the pre‐SDAWP group (21.2 vs. 12.0 mg, p < 0.0001) and for a significantly shorter median duration of time (4.0 vs. 3.0 days, p < 0.0001). There was no significant difference in the median length of stay (4.0 vs. 4.0 days, p = 0.50). The incidence of delirium tremens (21 vs. 7, p = 0.01) and need for transfer to a higher level of care (33 vs. 12, p = 0.002) was significantly lower in the post‐SDAWP group.
Conclusion
The SDAWP has provided significant improvements in AWS management in our institution and may potentially serve as a template for wider use in other inpatient settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Section of Hospitalist Medicine, Jennifer Moreno Veterans Affairs Medical Center, San Diego, California, USA.
- Department of Pharmacy, Jennifer Moreno Veterans Affairs Medical Center, San Diego, California, USA.
ORCID-Profile: Kevin M Krcmarik
Zitieren
APA
Krcmarik, K. M., Hulley, B. J., Huang, J., Juang, D., Cadman, P., Urbiztondo, C., Vo, C., Vargas, J., Motarjemi, R., Moinizandi, T., & Kwan, B. (2023). Assessment of a modified MINDS ‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.2855
Vancouver
Krcmarik KM, Hulley BJ, Huang J, Juang D, Cadman P, Urbiztondo C, et al. Assessment of a modified MINDS ‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2023. doi:10.1002/phar.2855
BibTeX
@article{Krcmarik2023,
author = {Krcmarik, Kevin M and Hulley, Benjamin J and Huang, Jiayi and Juang, Derek and Cadman, Peter and Urbiztondo, Charisma and Vo, Christine and Vargas, Jaclyn and Motarjemi, Ramin and Moinizandi, Tarlan and Kwan, Brian},
title = {Assessment of a modified MINDS ‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2023},
doi = {10.1002/phar.2855}
}
EUVIMED